US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 22.330
  • -0.760-3.29%
Close Nov 25 16:00 ET
816.75MMarket Cap-11369P/E (TTM)

Rapport Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-202.64%-16.42M
-147.80%-16.35M
-266.90%-17.62M
-27.18M
-10.36M
-5.42M
-6.6M
-4.8M
Net income from continuing operations
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
---34.79M
---13.52M
---8.71M
---6.41M
---6.15M
Operating gains losses
--0
--0
617.48%7.39M
--1.12M
--94K
--0
--0
--1.03M
Depreciation and amortization
852.17%219K
890.48%208K
913.33%152K
--112K
--53K
--23K
--21K
--15K
Other non cash items
--162K
--159K
--156K
--267K
--148K
----
----
----
Change In working capital
-120.88%-477K
89.34%-123K
-648.10%-3.16M
--2.65M
--1.94M
--2.28M
---1.15M
---422K
-Change in prepaid assets
-232.28%-672K
173.95%900K
-241.58%-2.07M
---3.2M
---1.89M
--508K
---1.22M
---606K
-Change in payables and accrued expense
-79.06%364K
-2,305.00%-882K
-367.70%-953K
--6.24M
--4.1M
--1.74M
--40K
--356K
-Change in other current assets
--0
4.35%24K
115.70%27K
---240K
---115K
--24K
--23K
---172K
-Change in other current liabilities
-1,307.14%-169K
---165K
---161K
---144K
---158K
--14K
--0
--0
Cash from discontinued investing activities
Operating cash flow
-202.64%-16.42M
-147.80%-16.35M
-266.90%-17.62M
---27.18M
---10.36M
---5.42M
---6.6M
---4.8M
Investing cash flow
Cash flow from continuing investing activities
-101,901.92%-53.04M
-124,439.53%-107.1M
-68,631.15%-41.93M
-78.86M
-78.66M
-52K
-86K
-61K
Net PPE purchase and sale
-169.23%-140K
-1,024.42%-967K
-1,657.38%-1.07M
---1.64M
---1.44M
---52K
---86K
---61K
Net investment purchase and sale
---52.9M
---106.14M
---40.85M
---77.22M
---77.22M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-101,901.92%-53.04M
-124,439.53%-107.1M
-68,631.15%-41.93M
---78.86M
---78.66M
---52K
---86K
---61K
Financing cash flow
Cash flow from continuing financing activities
-101.63%-1.39M
177,158.89%159.35M
6.09%63.66M
145.14M
-140K
85.36M
-90K
60.01M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
Net common stock issuance
-34,750.00%-1.39M
530,230.00%159.1M
--0
--50K
--0
---4K
--30K
--24K
Net preferred stock issuance
--0
63.75%-29K
6.57%63.94M
--145.22M
---6K
--85.31M
---80K
--60M
Net other financing activities
----
----
-1,472.22%-283K
---134K
----
----
---40K
---18K
Cash from discontinued financing activities
Financing cash flow
-101.63%-1.39M
177,158.89%159.35M
6.09%63.66M
--145.14M
---140K
--85.36M
---90K
--60.01M
Net cash flow
Beginning cash position
38.65%110.27M
-13.82%74.37M
125.47%70.25M
--31.16M
--159.41M
--79.53M
--86.3M
--31.16M
Current changes in cash
-188.69%-70.85M
629.85%35.9M
-92.53%4.12M
--39.1M
---89.16M
--79.88M
---6.78M
--55.14M
End cash Position
-75.27%39.42M
38.65%110.27M
-13.82%74.37M
--70.25M
--70.25M
--159.41M
--79.53M
--86.3M
Free cash flow
-202.32%-16.56M
-159.07%-17.32M
-284.35%-18.69M
---28.82M
---11.79M
---5.48M
---6.69M
---4.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -202.64%-16.42M-147.80%-16.35M-266.90%-17.62M-27.18M-10.36M-5.42M-6.6M-4.8M
Net income from continuing operations -101.37%-17.54M-182.65%-18.12M-268.78%-22.67M---34.79M---13.52M---8.71M---6.41M---6.15M
Operating gains losses --0--0617.48%7.39M--1.12M--94K--0--0--1.03M
Depreciation and amortization 852.17%219K890.48%208K913.33%152K--112K--53K--23K--21K--15K
Other non cash items --162K--159K--156K--267K--148K------------
Change In working capital -120.88%-477K89.34%-123K-648.10%-3.16M--2.65M--1.94M--2.28M---1.15M---422K
-Change in prepaid assets -232.28%-672K173.95%900K-241.58%-2.07M---3.2M---1.89M--508K---1.22M---606K
-Change in payables and accrued expense -79.06%364K-2,305.00%-882K-367.70%-953K--6.24M--4.1M--1.74M--40K--356K
-Change in other current assets --04.35%24K115.70%27K---240K---115K--24K--23K---172K
-Change in other current liabilities -1,307.14%-169K---165K---161K---144K---158K--14K--0--0
Cash from discontinued investing activities
Operating cash flow -202.64%-16.42M-147.80%-16.35M-266.90%-17.62M---27.18M---10.36M---5.42M---6.6M---4.8M
Investing cash flow
Cash flow from continuing investing activities -101,901.92%-53.04M-124,439.53%-107.1M-68,631.15%-41.93M-78.86M-78.66M-52K-86K-61K
Net PPE purchase and sale -169.23%-140K-1,024.42%-967K-1,657.38%-1.07M---1.64M---1.44M---52K---86K---61K
Net investment purchase and sale ---52.9M---106.14M---40.85M---77.22M---77.22M--0--0--0
Cash from discontinued investing activities
Investing cash flow -101,901.92%-53.04M-124,439.53%-107.1M-68,631.15%-41.93M---78.86M---78.66M---52K---86K---61K
Financing cash flow
Cash flow from continuing financing activities -101.63%-1.39M177,158.89%159.35M6.09%63.66M145.14M-140K85.36M-90K60.01M
Net issuance payments of debt --------------0----------------
Net common stock issuance -34,750.00%-1.39M530,230.00%159.1M--0--50K--0---4K--30K--24K
Net preferred stock issuance --063.75%-29K6.57%63.94M--145.22M---6K--85.31M---80K--60M
Net other financing activities ---------1,472.22%-283K---134K-----------40K---18K
Cash from discontinued financing activities
Financing cash flow -101.63%-1.39M177,158.89%159.35M6.09%63.66M--145.14M---140K--85.36M---90K--60.01M
Net cash flow
Beginning cash position 38.65%110.27M-13.82%74.37M125.47%70.25M--31.16M--159.41M--79.53M--86.3M--31.16M
Current changes in cash -188.69%-70.85M629.85%35.9M-92.53%4.12M--39.1M---89.16M--79.88M---6.78M--55.14M
End cash Position -75.27%39.42M38.65%110.27M-13.82%74.37M--70.25M--70.25M--159.41M--79.53M--86.3M
Free cash flow -202.32%-16.56M-159.07%-17.32M-284.35%-18.69M---28.82M---11.79M---5.48M---6.69M---4.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday+1.40%